SlimAmerica appeals NAD decision that supplement weight-loss claims be discontinued.
This article was originally published in The Tan Sheet
Executive Summary
SLIMAMERICA SUPPLEMENT WEIGHT LOSS CLAIMS REFERRED TO NARB at the company's request, following an inquiry into the claims by the National Advertising Division of the Council of Better Business Bureaus, NAD reported Aug. 5. SlimAmerica is asking the National Advertising Review Board to review NAD's recommendation that efficacy and performance claims for the company's Super Formula Weight-Loss Supplement be discontinued until adequate support for the ad can be generated.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning